Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05358522 · ClinicalTrials.gov registry record · NA

Increasing Implementation of Post-Operative Opioid Prescribing Guidelines

A NA study of Surgery and Opioid Use, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
26,562
Enrollment target
1
Study location

NCT05358522: Completed NA study of Surgery and Opioid Use, sponsored by University of Pennsylvania.

NCT05358522 is a NA study of Surgery and Opioid Use that has completed, run by University of Pennsylvania. The registered enrollment target is 26,562 participants, below the 52,630-participant average among 120 other Surgery trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05358522, a NA study of Surgery and Opioid Use, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
26,562 participants
Enrollment target
1
Study location

Study Summary

The objective of this research study is to evaluate the effect of a quality improvement initiative carried out by a health system opioid stewardship task force aiming to increase clinician post-operative prescribing adherence with procedure specific guidelines that were developed using patient reported data. The feedback compares the clinician's average number of opioid pills prescribed after a given procedure to other clinicians in the health system and to the health system guideline recommended amount based on patient reported data on opioid pills taken for that procedure. The feedback also provides historical data on mean patient reported number opioid pills taken following a given procedure and on patients' ability to manage pain among those who received guideline adherent prescriptions compared with patients who received greater than the guideline recommended amount.

Primary Outcome

Proportion of eligible surgical cases who received a guideline-adherent opioid prescription

Interventions

  • OTHER Opioid Prescribing Report Cards

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 26,562 participants
Start Date 2022-06-01
Est. Completion 2023-11-05
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT05358522 record still lists

NCT05358522 is an interventional study that assigns participants to a tested intervention. Its 26,562 participants enrollment target places it among the larger protocols in the corpus, below the 52,630-participant average among 120 other Surgery trials with a reported enrollment target (50% lower).

The record links to 4 conditions, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which Opioid Prescribing Report Cards is the first listed.

NCT05358522 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05358522 about?

NCT05358522 is a clinical study titled "Increasing Implementation of Post-Operative Opioid Prescribing Guidelines". The objective of this research study is to evaluate the effect of a quality improvement initiative carried out by a health system opioid stewardship task force aiming to increase clinician post-operative prescribing adherence with procedure specific guidelines that were developed using patient repor...

What is the current status of trial NCT05358522?

This trial is currently completed. It is a NA study. The enrollment target is 26,562 participants. The study started on 2022-06-01. Estimated completion is 2023-11-05.

What conditions does trial NCT05358522 study?

This clinical trial studies the following conditions: Surgery, Opioid Use, Opioid Misuse, Prescription Opioid Misuse.

What interventions are being tested in trial NCT05358522?

The interventions under investigation include: Opioid Prescribing Report Cards (OTHER).

Who is sponsoring clinical trial NCT05358522?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05358522 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05358522's enrollment target sits among peer trials

26,562 4th of 120 higher than 117 of 120 other Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04678193 · 27,000 participants

    COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy

  • NCT04494945 · 27,500 participants · NA

    Identifying and Caring for Individuals With Inherited Cancer Syndrome

  • NCT07300839 · 25,500 participants · Phase 3

    A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

  • NCT03175302 · 25,240 participants

    PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05358522, the US trial registry maintained by the National Library of Medicine. NCT05358522 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.